Agrin and microvascular damage in Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 2, 2000, Pages 349-355

  Berzin, Tyler M ^a   Zipser, Brian D ^a   Rafii, Michael S ^b   Kuo Leblanc, Victoria ^a   Yancopouloš, George D ^c   Glass, David J ^c   Fallon, Justin R ^b   Stopa, Edward G ^a,d  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Agrin; Alzheimer's Disease; Blood brain barrier; Heparan sulfate proteoglycans; Laminin; Prothrombin; Vascular basement membrane

Indexed keywords

AGRIN; AMYLOID BETA PROTEIN; LAMININ; PROTEOHEPARAN SULFATE; PROTHROMBIN;

ADULT; AGED; ALZHEIMER DISEASE; AUTOPSY; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; NEUROFIBRILLARY TANGLE; NEUROMUSCULAR SYNAPSE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SENILE PLAQUE; SOLUBILITY; TISSUE DISTRIBUTION; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AGRIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN CHEMISTRY; CAPILLARIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MIDDLE AGED; PROTHROMBIN;

EID: 0034603407     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00121-4     Document Type: Conference Paper

References (46)

1. Barber A.J., Lieth E. Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. Dev Dyn. 208:1997;62-74.
2. Bowe M.A., Fallon J.R. The role of agrin in synapse formation. Annu Rev Neurosci. 18:1995;443-462.
3. Bowen D.C., Sugiyama J., Ferns M., Hall Z.W. Neural agrin activates a high-affinity receptor in C2 muscle cells that is unresponsive to muscle agrin. J Neurosci. 16:1996;3791-3797.
4. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
5. Buee L., Hof P.R., Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann N Y Acad Sci. 826:1997;7-24.
6. Campagna J.A., Ruegg M.A., Bixby J.L. Evidence that agrin directly influences presynaptic differentiation at neuromuscular junctions in vitro. Eur J Neurosci. 9:1997;2269-2283.
7. Castillo G.M., Ngo C., Cummings J., Wight T.N., Snow A.D. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem. 69:1997;2452-2465.
8. Cohen N.A., Kaufmann W.E., Worley P.F., Rupp F. Expression of agrin in the developing and adult rat brain. Neuroscience. 76:1997;581-596.
9. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature. 288:1980;279-280.
10. Davies C.A., Mann D.M., Sumpter P.Q., Yates P.O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci. 78:1987;151-164.
11. de la Torre JC. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann N Y Acad Sci 1997;26:826:75-91.
12. Denzer A.J., Brandenberger R., Gesemann M., Chiquet M., Ruegg M.A. Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol. 137:1997;671-683.
13. Donahue J.E., Berzin T.M., Rafii M.S., et al. Agrin in Alzheimer's disease altered solubility and abnormal distribution within microvasculature and brain parenchyma . Proc Natl Acad Sci U S A. 96:1999;6468-6472.
14. Ferns M., Hoch W., Campanelli J.T., Rupp F., Hall Z.W., Scheller R.H. RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubes. Neuron. 8:1992;1079-1086.
15. Garcia V.V., Alberca I., Borrasca A.L. Factor VIII-related antigen in cerebrospinal fluid. Thromb Haemost. 49:1983;142-143.
16. Geddes J.W., Monaghan D.T., Cotman C.W., Lott I.T., Kim R.C., Chui H.C. Plasticity of hippocampal circuitry in Alzheimer's disease. Science. 230:1985;1179-1181.
17. Halfter W. A heparan sulfate proteoglycan in developing avian axonal tracts. J Neurosci. 13:1993;2863-2873.
18. Halfter W., Schurer B., Yip J., et al. Distribution and substrate properties of agrin, a heparan sulfate proteoglycan of developing axonal pathways. J Comp Neurol. 383:1997;1-17.
19. Halfter W., Dong S., Schurer B., Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem. 273:1998;25404-25412.
20. Hamos J.E., DeGennaro L.J., Drachman D.A. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 39:1989;355-361.
21. Hilgenberg L.G., Hoover C.L., Smith M.A. Evidence of an agrin receptor in cortical neurons. J Neurosci. 19:1999;7384-7393.
22. Hoch W., Ferns M., Campanelli J.T., Hall Z.W., Scheller R.H. Developmental regulation of highly active alternatively spliced forms of agrin. Neuron. 11:1993;479-490.
23. Kalman J., Juhasz A., Csaszar A., et al. Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population. Acta Neurol Scand. 98:1998;166-188.
24. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol. 42:1985;1097-1105.
25. Kroger S., Horton S.E., Honig L.S. The developing avian retina expresses agrin isoforms during synaptogenesis. J Neurobiol. 29:1996;165-182.
26. Larner A.J. The cortical neuritic dystrophy of Alzheimer's disease nature, significance, and possible pathogenesis . Dementia. 6:1995;218-224.
27. Lassmann H., Weiler R., Fischer P., et al. Synaptic pathology in Alzheimer's disease immunological data for markers of synaptic and large dense-core vesicles . Neuroscience. 46:1992;1-8.
28. Lewczuk P., Reiber H., Ehrenreich H. Prothrombin in normal human cerebrospinal fluid originates from the blood. Neurochem Res. 23:1998;1027-1030.
29. Mcarron M.O., Muir K.W., Weir C.J., et al. The apolipoprotein E epsilon 4 allele and outcome in cerebrovascular disease. Stroke. 29:1998;1882-1887.
30. Narindrasorasak S., Lowery D.E., Altman R.A., Gonzalez-DeWhitt P.A., Greenberg B.D., Kisilevsky R. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab Invest. 67:1992;643-652.
31. Nitkin R.M., Smith M.A., Magill C., et al. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J Cell Biol. 105:1987;2471-2478.
32. O'Connor L.T., Lauterborn J.C., Gall C.M., Smith M.A. Localization and alternative splicing of agrin mRNA in adult rat brain transcripts encoding isoforms that aggregate acetylcholine receptors are not restricted to cholinergic regions . J Neurosci. 14:1994;1141-1152.
33. Perlmutter L.S., Barron E., Saperia D., Chui H.C. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J Neurosci Res. 30:1991;673-681.
34. Perlmutter L.S. Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol. 9:1994;33-40.
35. Perry G., Siedlak S.L., Richey P., et al. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci. 11:1991;3679-3683.
36. Reist N.E., Magill C., McMahan U.J. Agrin-like molecules at synaptic sites in normal, denervated, and damaged skeletal muscles. J Cell Biol. 105:1987;2457-2469.
37. Roses A.D. The Alzheimer diseases. Curr Opin Neurobiol. 6:1996;644-650.
38. Sims N.R., Bowen D.M., Allen S.J., et al. Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem. 40:1983;503-509.
39. Small D.H., Nurcombe V., Reed G., et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci. 14:1994;2117-2127.
40. Small D.H., Williamson T., Reed G., et al. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease. Ann N Y Acad Sci. 777:1996;316-321.
41. Smith M.A., Yao Y.M., Reist N.E., Magill C., Wallace B.G., McMahan U.J. Identification of agrin in electric organ extracts and localization of agrin-like molecules in muscle and central nervous system. J Exp Biol. 132:1987;223-230.
42. Snow A.D., Mar H., Nochlin D., et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol. 133:1988;456-463.
43. Snow A.D., Sekiguchi R., Nochlin D., et al. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron. 12:1994;219-234.
44. Tsen G., Halfter W., Kroger S., Cole G.J. Agrin is a heparan sulfate proteoglycan. J Biol Chem. 270:1995;3392-3399.
45. Wallace B.G. Agrin-induced specializations contain cytoplasmic, membrane, and extracellular matrix-associated components of the postsynaptic apparatus. J Neurosci. 9:1989;1294-1302.
46. Zhang P., Hirsch E.C., Damier P., Duyckaerts C., Javoy-Agid F. c-fos protein-like immunoreactivity distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease . Neuroscience. 46:1992;9-21.